EUVIMEDEUVIMED entdecken
Crossref

Identification and development of oxoquinazoline derivatives as novel mycobacterial inhibitors targeting cell wall synthesis enzyme

Dhramarajan Sriram, Prasanthi Malapati, KrishnaSiva Vagolu

Biomedical and Biotechnology Research Journal (BBRJ) · 2018

DOI: 10.4103/bbrj.bbrj_101_17 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomedical and Biotechnology Research Journal (BBRJ), 2018. Verfasst von Dhramarajan Sriram und 2 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Tuberculosis (TB) still remains the leading cause of death worldwide and was unanswered till date. Available treatment strategies have many drawbacks such as longer treatment period, side effects, and drug interactions, which result in patient noncompliance. In the present work, we thrived to develop inhibitors against unexplored key target glutamate racemase.

Methods

Lead was identified from in-house database using differential scanning fluorimetry, inhibitors were developed by lead derivatization technique and evaluated them by various biological assays.

Results

In oxoquinazoline series, compounds 18 (10.1 ± 0.62 μM) and 22 (5.23 ± 0.34 μM) were found to be the most promising potent inhibitors among all. These compounds also showed their inhibition on replicating and nonreplicating bacteria.

Conclusion

Our attempt to develop the potent novel inhibitors against Mycobacterium tuberculosis resulted in developing few promising inhibitors, yet these compounds need further studies to answer all questions in drug discovery. Further optimization of compounds can result in still better compounds for treating TB.

Zitieren

APA

Sriram, D., Malapati, P., & Vagolu, K. (2018). Identification and development of oxoquinazoline derivatives as novel mycobacterial inhibitors targeting cell wall synthesis enzyme. Biomedical and Biotechnology Research Journal (BBRJ). https://doi.org/10.4103/bbrj.bbrj_101_17

Vancouver

Sriram D, Malapati P, Vagolu K. Identification and development of oxoquinazoline derivatives as novel mycobacterial inhibitors targeting cell wall synthesis enzyme. Biomedical and Biotechnology Research Journal (BBRJ). 2018. doi:10.4103/bbrj.bbrj_101_17

BibTeX
@article{Sriram2018,
  author = {Sriram, Dhramarajan and Malapati, Prasanthi and Vagolu, KrishnaSiva},
  title = {Identification and development of oxoquinazoline derivatives as novel mycobacterial inhibitors targeting cell wall synthesis enzyme},
  journal = {Biomedical and Biotechnology Research Journal (BBRJ)},
  year = {2018},
  doi = {10.4103/bbrj.bbrj_101_17}
}
Kostenlos starten →